These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1485 related articles for article (PubMed ID: 21219188)

  • 1. The inflammasome NLRs in immunity, inflammation, and associated diseases.
    Davis BK; Wen H; Ting JP
    Annu Rev Immunol; 2011; 29():707-35. PubMed ID: 21219188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation and Function of the Nucleotide Binding Domain Leucine-Rich Repeat-Containing Receptor, Pyrin Domain-Containing-3 Inflammasome in Lung Disease.
    Lee S; Suh GY; Ryter SW; Choi AM
    Am J Respir Cell Mol Biol; 2016 Feb; 54(2):151-60. PubMed ID: 26418144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nucleotide-binding oligomerization domain-like receptors and inflammasomes in the pathogenesis of non-microbial inflammation and diseases.
    Mason DR; Beck PL; Muruve DA
    J Innate Immun; 2012; 4(1):16-30. PubMed ID: 22067846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent advances in the NEK7-licensed NLRP3 inflammasome activation: Mechanisms, role in diseases and related inhibitors.
    Zhao N; Li CC; Di B; Xu LL
    J Autoimmun; 2020 Sep; 113():102515. PubMed ID: 32703754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inflammasomes: Key Mediators of Lung Immunity.
    Howrylak JA; Nakahira K
    Annu Rev Physiol; 2017 Feb; 79():471-494. PubMed ID: 28192059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression profile of innate immune receptors, NLRs and AIM2, in human colorectal cancer: correlation with cancer stages and inflammasome components.
    Liu R; Truax AD; Chen L; Hu P; Li Z; Chen J; Song C; Chen L; Ting JP
    Oncotarget; 2015 Oct; 6(32):33456-69. PubMed ID: 26378020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of human monocyte and macrophage polarization on NLR expression and NLRP3 inflammasome activation.
    Awad F; Assrawi E; Jumeau C; Georgin-Lavialle S; Cobret L; Duquesnoy P; Piterboth W; Thomas L; Stankovic-Stojanovic K; Louvrier C; Giurgea I; Grateau G; Amselem S; Karabina SA
    PLoS One; 2017; 12(4):e0175336. PubMed ID: 28403163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammasome Priming in Sterile Inflammatory Disease.
    Patel MN; Carroll RG; Galván-Peña S; Mills EL; Olden R; Triantafilou M; Wolf AI; Bryant CE; Triantafilou K; Masters SL
    Trends Mol Med; 2017 Feb; 23(2):165-180. PubMed ID: 28109721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inflammasome activation causes dual recruitment of NLRC4 and NLRP3 to the same macromolecular complex.
    Man SM; Hopkins LJ; Nugent E; Cox S; Glück IM; Tourlomousis P; Wright JA; Cicuta P; Monie TP; Bryant CE
    Proc Natl Acad Sci U S A; 2014 May; 111(20):7403-8. PubMed ID: 24803432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A role for the NLRP3 inflammasome in metabolic diseases--did Warburg miss inflammation?
    Wen H; Ting JP; O'Neill LA
    Nat Immunol; 2012 Mar; 13(4):352-7. PubMed ID: 22430788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sensing pathogens and danger signals by the inflammasome.
    Pedra JH; Cassel SL; Sutterwala FS
    Curr Opin Immunol; 2009 Feb; 21(1):10-6. PubMed ID: 19223160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of inflammasome activation.
    Man SM; Kanneganti TD
    Immunol Rev; 2015 May; 265(1):6-21. PubMed ID: 25879280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inflammasomes as therapeutic targets in human diseases.
    Li Y; Huang H; Liu B; Zhang Y; Pan X; Yu XY; Shen Z; Song YH
    Signal Transduct Target Ther; 2021 Jul; 6(1):247. PubMed ID: 34210954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inflammasomes and human autoimmunity: A comprehensive review.
    Yang CA; Chiang BL
    J Autoimmun; 2015 Jul; 61():1-8. PubMed ID: 26005048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Caspase-11 non-canonical inflammasome: a critical sensor of intracellular lipopolysaccharide in macrophage-mediated inflammatory responses.
    Yi YS
    Immunology; 2017 Oct; 152(2):207-217. PubMed ID: 28695629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The caspase-1 inflammasome: a pilot of innate immune responses.
    Yu HB; Finlay BB
    Cell Host Microbe; 2008 Sep; 4(3):198-208. PubMed ID: 18779046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The inflammasome in host defense.
    Chen G; Pedra JH
    Sensors (Basel); 2010; 10(1):97-111. PubMed ID: 22315529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The pathogenic role of the inflammasome in neurodegenerative diseases.
    Freeman LC; Ting JP
    J Neurochem; 2016 Jan; 136 Suppl 1():29-38. PubMed ID: 26119245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Inflammasomes and related diseases].
    Saito MK
    Nihon Rinsho Meneki Gakkai Kaishi; 2011; 34(1):20-8. PubMed ID: 21372510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extracellular acidosis is a novel danger signal alerting innate immunity via the NLRP3 inflammasome.
    Rajamäki K; Nordström T; Nurmi K; Åkerman KE; Kovanen PT; Öörni K; Eklund KK
    J Biol Chem; 2013 May; 288(19):13410-9. PubMed ID: 23530046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 75.